Immuneering

Price & Volume

Track all markets on TradingView

Stats

See more
Open
$8.16
Previous Close
$8
Day Range
$7.52-$8.16
52W Range
$1.10-$10.08
Market Cap
$383.6M
Shares Short
2M

Financials

See more
Revenue (12 Mos)
$455
Revenue Growth (YoY)
-99.8%
Gross Profit (12 Mos)
$158,830
Diluted EPS
-$1.90

News

See more

Yahoo Finance • yesterday

Biggest stock movers Thursday: INTC, RIG, and more

Yahoo Finance • 2 days ago

Immuneering Announces Pricing of $175 Million Underwritten Public Offering of Class A Common Stock and Concurrent $25 Million Private Placement of Class A Common Stock to Sanofi

Yahoo Finance • 2 days ago

Immuneering Announces Proposed Underwritten Public Offering of Class A Common Stock and Pre-Funded Warrants and Proposed Concurrent Private Placement of Class A Common Stock and Class B Common Stock to Sanofi

Yahoo Finance • 2 days ago

Immuneering Announces Extraordinary 86% Overall Survival at 9 Months in First-Line Pancreatic Cancer Patients Treated with Atebimetinib + mGnP

About

CEO
Dr. Benjamin J. Zeskind M.B.A., Ph.D.
Address
245 Main Street, Cambridge, MA, United States, 02142
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
54